FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry and concerns the use of alpha-hydroxycarbonyl compounds as reducing substances able to form cyclic dimers. Also, there are presented related methods for reducing the reduced compounds, especially activated by compound reduction. The examples of the used alpha-hydroxycarbonyl compounds are dihydroacetone, glyceraldehyde, erythrose, xylulose, erythrulose or 3-hydroxy-2-butanone.
EFFECT: reduction takes place in mild conditions and provides selective production of one of isomers of the reduced compound.
54 cl, 9 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF DANTROLENE AND DANTROLENE PRODRUGS FOR TREATMENT OF RADIATION EXPOSURE | 2019 |
|
RU2812220C2 |
| COMPOUNDS MODULATING INTRACELLULAR CALCIUM | 2008 |
|
RU2465272C2 |
| DANTROLENE PRODRUGS AND METHODS OF THEIR USE | 2018 |
|
RU2815017C2 |
| ALPHA-SUBSTITUTED OMEGA-3 LIPIDS, ACTIVATORS OR MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) | 2007 |
|
RU2507193C2 |
| CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
| BENZAMIDE DERIVATIVES HAVING ANTICANCER ACTIVITY, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2011 |
|
RU2565079C2 |
| METABOLITES OF ALPHA-HYDROXYLATED FATTY ACIDS, MEDICAL APPLICATIONS AND USE THEREOF AS BIOMARKERS | 2021 |
|
RU2841595C1 |
| PRODRUGS CONTAINING EXENDIN CONJUGATE-LINKER | 2011 |
|
RU2593774C2 |
| NEW NITROPHENYLPYRITE AND NITROPHENYLAZIRIDINE ALCOHOLS AND CORRESPONDING PHOSPHATES THEREOF AND USE THEREOF AS TARGETED CYTOTOXIC AGENTS | 2004 |
|
RU2372324C2 |
| 1-(2-FLUOROBIPHENYL-4-YL)-ALKYLCARBOXYLIC ACID DERIVATIVES FOR TREATING TRANSTHYRETIN AMYLOIDOSIS | 2011 |
|
RU2565066C2 |
